ImmuCell Corp. (ICCC)
5.84
-0.27
(-4.42%)
USD |
NASDAQ |
Feb 03, 16:00
5.85
+0.01
(+0.17%)
After-Hours: 20:00
ImmuCell Shareholders Equity (Quarterly) : 29.80M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 25.39B |
| Cumberland Pharmaceuticals, Inc. | 26.12M |
| AbbVie, Inc. | -2.642B |
| Precipio, Inc. | 13.75M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.73M |
| Total Liabilities (Quarterly) | 15.93M |
| Debt to Equity Ratio | 0.4566 |
| Current Ratio | 4.208 |
| Net Debt Paydown Yield | 0.79% |